To further confirm whether Syncytin-1 upregulated these downstream proteins through activating the MEK/ERK pathway in HCC cells, JTP-74057, an inhibitor of MEK1/2 activity [35], and GDC-0994, a highly selective ERK1/2 inhibitor [36], were used. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.